Vakiener Victoria
SEC Form 4 insider trading activity
Vakiener Victoria has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 23, 2025.
On the most recent filing, Vakiener Victoria is listed as Director at ARROWHEAD PHARMACEUTICALS, INC. Inside the rolling window, Vakiener Victoria reported no open-market purchases and 1 open-market sale totaling $679K in ARWR.
Companies traded
Other insiders at ARWR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$679K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vakiener Victoria made?
Vakiener Victoria has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Vakiener Victoria trade?
Vakiener Victoria has filed SEC Form 4 disclosures for 1 company, including ARWR.
When was Vakiener Victoria's most recent SEC Form 4 filing?
Vakiener Victoria's most recent SEC Form 4 filing on Tracefour is dated Dec 23, 2025.
What is Vakiener Victoria's total buy and sell value in the current window?
Inside the rolling retention window, Vakiener Victoria bought $0 and sold $679K based on SEC Form 4 filings.
What was Vakiener Victoria's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,040 ARWR shares on 2025-12-19, worth $679K, per SEC Form 4 filings.